Viewing Study NCT06889766

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2026-01-13 @ 1:21 AM
Study NCT ID: NCT06889766
Status: RECRUITING
Last Update Posted: 2025-04-20
First Post: 2025-03-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma
Sponsor: Centre Hospitalier Universitaire Vaudois
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Melanoma View
None Melanoma Metastatic View
None Sarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NY-ESO-1 View
None LauT-1 View
None TCR redirected T cell View
None metastatic melanoma View
None Sarcoma View
None autolog T-cell View